Приказ основних података о документу

dc.creatorCetenović, Bojana
dc.creatorColović, Bozana
dc.creatorVasilijić, Sasa
dc.creatorProkić, Bogomir Bolka
dc.creatorPasalić, Snežana
dc.creatorJokanović, Vukoman
dc.creatorTepavčević, Zvezdana
dc.creatorMarković, Dejan
dc.date.accessioned2020-06-03T14:21:30Z
dc.date.available2020-06-03T14:21:30Z
dc.date.issued2018
dc.identifier.issn0957-4530
dc.identifier.urihttps://vet-erinar.vet.bg.ac.rs/handle/123456789/1571
dc.description.abstractThe aim of this study was to investigate the biocompatibility of nanostructured materials based on highly active calcium silicates mixed with different radiocontrast agents in comparison to MTA(+) using in vitro and in vivo model. Morphology of materials samples was analyzed using SEM while the phase compositions were identified by XRD. pH values of materials suspensions were conducted by pH-meter. The cytotoxicity of materials solutions was tested by MTT test (100, 50, 25 and 12.5mg/ml). LDH and H-3-thymidine assay were utilized for biocompatibility investigations of materials eluates (24h, 7 day and 21 day). Eighteen Guinea pigs were used for intramuscular implantation, as teflon tubes with freshly prepared materials were placed into intramuscular pockets. All samples were composed of round and needle-like particles equally distributed with Ca/Si ratio 2.7 at%, with the presence of hydrated calcium silicate phases. The pH values of ALBO-MPCA(1) and ALBO-MPCA(2) were high alkaline, while in case of MTA(+) they were lower and continuously declined (p<0.05). Investigated materials didnt exhibit dose-dependent effect on metabolic activity of L929 cells (p>0.05). Significant differences in the percentage of cytotoxicity between diluted and undiluted extracts between all tested materials after 24h and 7 day were noticed (p<0.05). Increase in L929 cells proliferation was noticed in case of undiluted eluates of ALBO-MPCA(1) and ALBO-MPCA(2) after 7 day (p<0.05). There were no statistically significant differences in the intensity of inflammatory response between investigated materials and control group after 60 day (p>0.05). Evaluation of biocompatibility of both ALBO-MPCA(1) and ALBO-MPCA(2) indicate their potential clinical use. [GRAPHICS] .en
dc.publisherSpringer, Dordrecht
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172026/RS//
dc.rightsrestrictedAccess
dc.sourceJournal of Materials Science-Materials in Medicine
dc.titleNanostructured endodontic materials mixed with different radiocontrast agentsbiocompatibility studyen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractТепавчевић, Звездана; Марковић, Дејан; Пасалић, Снежана; Прокић, Богомир Болка; Цоловић, Бозана; Цетеновић, Бојана; Јокановић, Вукоман; Василијић, Саса;
dc.citation.volume29
dc.citation.issue12
dc.citation.spage190
dc.citation.other29(12): 190
dc.citation.rankM22
dc.identifier.wos000452711900004
dc.identifier.doi10.1007/s10856-018-6200-z
dc.identifier.pmid30536136
dc.identifier.scopus2-s2.0-85058111668
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу